ESMO ACROSS ONCOLOGY. WORLDWIDE Josep Tabernero ESMO President ESMO SUMMIT MIDDLE EAST Friday, 6 th April 2018
ESMO IN A NUTSHELL Europe s leading Medical Oncology Society ESMO is the leading European professional organisation for medical oncology, working across Europe and around the world to erase boundaries in cancer care and to provide medical oncology education within an integrated approach to cancer care
ESMO MISSION Educate and train persons involved in clinical cancer care and research Improve the quality of prevention, diagnosis, treatment, supportive and palliative care Disseminate knowledge in oncology to cancer patients and the public Promote education in oncology to ensure a high standard of qualification for medical oncologists within the multidisciplinary team Facilitate equal access to optimal cancer care for all cancer patients Advance the art, science, recognition, and practice of oncology Maintain liaisons with other oncology specialties, cancer leagues, universities, patient groups & where appropriate, the pharmaceutical industry
ESMO 2020 VISION Securing the best possible outcomes for people with cancer
Membership Clinical Practice OncologyPro Public Policy Conferences Career Development
ESMO MEMBERSHIP AND GLOBAL NETWORK Membership Distribution > 18,000 members North America 9% South America 6% Europe 55% Africa 5% Asia-Pacific 25% Over 150 countries Reciprocal membership agreements with 50 national oncology societies As of 31 December 2017
TOOLS AND RESOURCES OncologyPRO ESMO s online education portal Direct access 24/7 to oncology news, scientific and educational resources Scientific and educational online portal Continuously updated Information by disease-type
DISSEMINATING CANCER INFORMATION WORLDWIDE The official journal of ESMO, providing rapid and efficient peerreview publications on innovative cancer treatments, or translational work related to oncology and precision medicine. Ranked #10 in Oncology Over 4.3 million downloads in 2016 Accessed by 3,569 institutions worldwide Over 2 million unique readers in 188 countries Over 15,000 followers on Twitter Official journal of JSMO ESMO s online-only, peerreviewed open access journal, dedicated to publishing highquality medical research and educational content from all disciplines of oncology. Indexing: Google Scholar, PubMed Central, Emerging Sources Citation Index (Web of Science) Global reach: 241 submissions from 34 countries Broad coverage: 157 papers published Affiliations with AIOM, CSCO, KACO, JSMO
SETTING THE STANDARDS OF CARE FOR CLINICAL CANCER PRACTICE ESMO Clinical Practice Guidelines Evidencebased guidelines to support clinicians in delivering patients the best cancer treatment options Latest information on diagnostic criteria, disease staging, risk assessment, treatment plan and follow-up Regularly updated and reviewed by leading oncology experts More than 70 available from the ESMO website or the ESMO mobile app Approximately 20 patient friendly versions available
ESMO MEETINGS Exchange expertise and knowledge at our first class events Congresses Symposia Educational Courses
ENSURING ACCESS TO CANCER MEDICINES A critical issue for medical oncologists To treat patients according to the ESMO Clinical Practice Guidelines, medical oncologists need to have access to the cancer medicines recommended in the guidelines. In Europe ESMO works closely with the European Medicines Agency and the European Network of Health Technology Assessment in order to harmonise the approval and reimbursement process for cancer medicines in Europe. ESMO has conducted international surveys on the availability of cancer medicines and has proposed recommendations on how to reduce the barriers. ESMO keeps its members updated on the latest in personalised medicine, immunotherapies and biosimilars in a rapidlyadvancing landscape of new cancer treatments
ESMO: MEDICAL ONCOLOGY EDUCATION BROUGHT DIRECTLY TO YOU A global society with a tailored education offer to meet your local needs
ESMO SUMMIT MIDDLE EAST 2018 Dubai, United Arab Emirates - 06 Apr - 07 Apr 2018 Oncology Updates: From Evidence to Practice Designed to address the specific challenges faced by oncology professionals practising in this region To provide the oncology community with a summary of the most significant treatment advances presented at the ESMO annual congress Local and international experts covering the cancer types most frequently encountered in Sub- Saharan Africa To review the current standard of care for key malignancies from a local and international perspective Series of clinical case presentations followed by time for discussion To discuss the current controversies in the management of specific cancers
ESMO SUMMIT MIDDLE EAST 2018 Participants Overview Participants Category Faculty 32 Delegates 263 ESMO Staff 3 Total 298
ESMO SUMMIT MIDDLE EAST 2018 Country break down (Delegates: 250+) Country Delegate Australia 1 Canada 1 Czech Republic 1 UAE 55% Iraq 18% Lebanon 7,3% Saudi Arabia 4,7% China 3 Egypt 6 France 1 Germany 1 Hungary 1 India 1 Iran 3 Iraq 42 Jordan 6 Korea 1 Saudi Arabia 12 Kuwait 2 Lebanon 17 Netherlands 1 Philippines 6 Syria 1 UAE 156 Total 263